Neuman B, Smart A, Gilmer O, Smyth R, Vaas J, Boker N
Proc Natl Acad Sci U S A. 2025; 122(7):e2413675122.
PMID: 39928875
PMC: 11848433.
DOI: 10.1073/pnas.2413675122.
Hoferle P, Anderson T, Kirchdoerfer R
bioRxiv. 2024; .
PMID: 39091740
PMC: 11291119.
DOI: 10.1101/2024.07.23.604833.
Han X, Huang Y, Hao J
Biology (Basel). 2024; 13(7).
PMID: 39056685
PMC: 11273894.
DOI: 10.3390/biology13070491.
Lauber C, Zhang X, Vaas J, Klingler F, Mutz P, Dubin A
PLoS Pathog. 2024; 20(4):e1012163.
PMID: 38648214
PMC: 11065284.
DOI: 10.1371/journal.ppat.1012163.
Keep S, Dowgier G, Lulla V, Britton P, Oade M, Freimanis G
J Virol. 2023; 97(3):e0003823.
PMID: 36779761
PMC: 10062133.
DOI: 10.1128/jvi.00038-23.
Potential Inhibitors of SARS-CoV-2 Main Protease (M) Identified from the Library of FDA-Approved Drugs Using Molecular Docking Studies.
Verma D, Kapoor S, Das S, Thakur K
Biomedicines. 2023; 11(1).
PMID: 36672593
PMC: 9856154.
DOI: 10.3390/biomedicines11010085.
Recent Emergence of Bovine Coronavirus Variants with Mutations in the Hemagglutinin-Esterase Receptor Binding Domain in U.S. Cattle.
Workman A, McDaneld T, Harhay G, Das S, Loy J, Hause B
Viruses. 2022; 14(10).
PMID: 36298681
PMC: 9607061.
DOI: 10.3390/v14102125.
Genomics and pathogenesis of the avian coronavirus infectious bronchitis virus.
Quinteros J, Noormohammadi A, Lee S, Browning G, Diaz-Mendez A
Aust Vet J. 2022; 100(10):496-512.
PMID: 35978541
PMC: 9804484.
DOI: 10.1111/avj.13197.
Proteolytic Processing of the Coronavirus Replicase Nonstructural Protein 14 Exonuclease Is Not Required for Virus Replication but Alters RNA Synthesis and Viral Fitness.
Anderson-Daniels J, Gribble J, Denison M
J Virol. 2022; 96(16):e0084122.
PMID: 35924922
PMC: 9400476.
DOI: 10.1128/jvi.00841-22.
Genome Sequence Variations of Infectious Bronchitis Virus Serotypes From Commercial Chickens in Mexico.
Kariithi H, Volkening J, Leyson C, Afonso C, Christy N, Decanini E
Front Vet Sci. 2022; 9:931272.
PMID: 35903135
PMC: 9315362.
DOI: 10.3389/fvets.2022.931272.
Length-dependent motions of SARS-CoV-2 frameshifting RNA pseudoknot and alternative conformations suggest avenues for frameshifting suppression.
Yan S, Zhu Q, Jain S, Schlick T
Nat Commun. 2022; 13(1):4284.
PMID: 35879278
PMC: 9310368.
DOI: 10.1038/s41467-022-31353-w.
Engineering and Characterization of Avian Coronavirus Mutants Expressing Fluorescent Reporter Proteins from the Replicase Gene.
Xing N, Wang Z, Wang J, Nascimento M, Jongkaewwattana A, Trimpert J
J Virol. 2022; 96(14):e0065322.
PMID: 35862676
PMC: 9327687.
DOI: 10.1128/jvi.00653-22.
Thinking Outside the Frame: Impacting Genomes Capacity by Programmed Ribosomal Frameshifting.
Riegger R, Caliskan N
Front Mol Biosci. 2022; 9:842261.
PMID: 35281266
PMC: 8915115.
DOI: 10.3389/fmolb.2022.842261.
Secondary structural ensembles of the SARS-CoV-2 RNA genome in infected cells.
Lan T, Allan M, Malsick L, Woo J, Zhu C, Zhang F
Nat Commun. 2022; 13(1):1128.
PMID: 35236847
PMC: 8891300.
DOI: 10.1038/s41467-022-28603-2.
Identifying Inhibitors of -1 Programmed Ribosomal Frameshifting in a Broad Spectrum of Coronaviruses.
Munshi S, Neupane K, Ileperuma S, Halma M, Kelly J, Halpern C
Viruses. 2022; 14(2).
PMID: 35215770
PMC: 8876150.
DOI: 10.3390/v14020177.
Chicken-Derived Pattern Recognition Receptor chLGP2 Inhibits the Replication and Proliferation of Infectious Bronchitis Virus.
Wang K, Cui P, Ni R, Gong H, Li H, Yan W
Front Microbiol. 2022; 12:810215.
PMID: 35145497
PMC: 8824401.
DOI: 10.3389/fmicb.2021.810215.
Identification of Amino Acids within Nonstructural Proteins 10 and 14 of the Avian Coronavirus Infectious Bronchitis Virus That Result in Attenuation and .
Keep S, Stevenson-Leggett P, Dowgier G, Everest H, Freimanis G, Oade M
J Virol. 2022; 96(6):e0205921.
PMID: 35044208
PMC: 8941869.
DOI: 10.1128/jvi.02059-21.
Length-dependent motions of SARS-CoV-2 frameshifting RNA pseudoknot and alternative conformations suggest avenues for frameshifting suppression.
Yan S, Zhu Q, Jain S, Schlick T
Res Sq. 2022; .
PMID: 35018371
PMC: 8750709.
DOI: 10.21203/rs.3.rs-1160075/v1.
Biology and Pathogenesis of SARS-CoV-2: Understandings for Therapeutic Developments against COVID-19.
Sharma H, Latimore C, Matthews Q
Pathogens. 2021; 10(9).
PMID: 34578250
PMC: 8470303.
DOI: 10.3390/pathogens10091218.
SARS-CoV-2, Zika viruses and mycoplasma: Structure, pathogenesis and some treatment options in these emerging viral and bacterial infectious diseases.
Ferreira G, Santander A, Savio F, Guirado M, Sobrevia L, Nicolson G
Biochim Biophys Acta Mol Basis Dis. 2021; 1867(12):166264.
PMID: 34481867
PMC: 8413106.
DOI: 10.1016/j.bbadis.2021.166264.